Charles Schwab Investment Management Inc Sage Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 446,178 shares of SAGE stock, worth $2.89 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
446,178
Previous 462,309
3.49%
Holding current value
$2.89 Million
Previous $2.51 Million
41.31%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding SAGE
# of Institutions
218Shares Held
50MCall Options Held
220KPut Options Held
312K-
Black Rock Inc. New York, NY5.22MShares$33.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$32.9 Million0.0% of portfolio
-
Madison Avenue Partners, LP New York, NY4.48MShares$29 Million4.6% of portfolio
-
Tig Advisors, LLC New York, NY2.73MShares$17.7 Million1.36% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.09MShares$13.5 Million0.02% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $385M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...